A VALUED CUSTOMER OF THIRDEYE DATA

Stryker: predicting battery life without running the battery to failure

Stryker is one of the world’s leading medical technology companies, with products across medical and surgical, neurotechnology, orthopaedics and spine. In devices that clinicians rely on during procedures, how long a battery will last is not a convenience question. Knowing it accurately, early, and without destroying the battery to find out is a genuine research and development constraint.

LOCATION

Portage, Michigan, United States

COMPANY SIZE

Fortune 500 Company

INDUSTRY
The image displays the official logo of Stryker

Predicting remaining battery life from early cycle data

Battery life is defined by the number of charge and discharge cycles a cell will complete. Establishing that number by testing means cycling the battery until it degrades, which takes as long as the battery lasts and consumes the battery in the process. At the volumes a manufacturer needs to test, that is prohibitive in both time and cost.

ThirdEye Data built a machine learning model that predicts remaining life from early cycle test data, so the answer arrives from the beginning of a test rather than the end of one. The work involved substantial feature processing, both selecting which signals carry information and constructing new ones from them, followed by training and evaluating several different kinds of regression model rather than committing to one approach at the outset.

Two further elements made the difference between a model and a working method. A reinforcement learning component guides the testing process itself, so the tests being run are the ones that will most improve the prediction. And an active learning approach decides which batteries are worth testing further, concentrating effort where uncertainty is highest rather than spreading it evenly.

That second part is the one that changes the economics. Predicting from existing data is useful. Deciding what to test next is what reduces how much testing has to happen at all.

Remaining battery life is predicted from early cycle data rather than established by running each battery to the end of its life.

Related solution: machine learning for research and development

Research and development has a particular relationship with machine learning. The data is often small, expensive and generated on purpose rather than collected passively, which inverts the usual assumptions. Techniques built for abundant cheap data do not transfer well, and the most valuable contribution is frequently not a better prediction but a reduction in how much experimentation is needed to reach a conclusion.

ThirdEye Data works on that second problem as well as the first. Alongside the predictive model we build the layer that decides what to test next, which concentrates expensive physical testing where it will change the answer. For a medical device manufacturer, that meant predicting battery life from early data and directing which batteries warranted further testing. The same approach applies anywhere physical testing is the bottleneck: materials, manufacturing process development, and component qualification.

Explore our predictive modelling solutions  ›

 

DO YOU HAVE A SIMILAR USE CASE?

Talk to our team to learn more about what we did for Stryker and how that experience applies to your own environment.

Explore What We Did for Other Customers

Amgen logo in blue, representing a key client in ThirdEye Data's portfolio showcasing data engineering and AI solutions for the healthcare industry.
The image represents the logo of Kobie
Official Prochain Company Logo for Brand Identity
walsworth valuable customer
The image displays the  logo of Marvell
CONTACT US